Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.42), $0.12 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.17 million versus the consensus estimate of $3.33 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.